Meanwhile, more than a dozen others are being developed. MODEL-AD consortium creates new models of late-onset AD. In LOAD2 ...

NSD-2 is crucial for AR activity in prostate cancer, promoting tumor growth and offering a potential therapeutic target for advanced prostate cancer treatment.

To date, there have not been any reported robust small-animal models of human parainfluenza virus type 3 (HPIV-3) infection. Researchers from Katholieke Universiteit Leuven and affiliated ...

We are excited to announce that Health Canada has issued a no objection letter allowing us to move forward with our first clinical trial evaluating briquilimab in asthma, and we look forward to ...

Investigators are constantly aiming to identify new therapeutic approaches for regenerative medicine. Recent strategies have focused on harnessing the power of the body's own tissue healing and repair ...